Dokument: Epidemiologie, Management und Behandlungsergebnisse von Infektionen, Sepsis und Septischem Schock in der Zentralen Notaufnahme
Titel: | Epidemiologie, Management und Behandlungsergebnisse von Infektionen, Sepsis und Septischem Schock in der Zentralen Notaufnahme | |||||||
Weiterer Titel: | Epidemiology, management and treatment outcomes of infections, sepsis and septic shock in the central emergency department | |||||||
URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=67392 | |||||||
URN (NBN): | urn:nbn:de:hbz:061-20241118-095100-7 | |||||||
Kollektion: | Dissertationen | |||||||
Sprache: | Deutsch | |||||||
Dokumententyp: | Wissenschaftliche Abschlussarbeiten » Dissertation | |||||||
Medientyp: | Text | |||||||
Autor: | Wolfertz, Nicole [Autor] | |||||||
Dateien: |
| |||||||
Beitragende: | Prof. Dr. med. Bernhard Michael [Gutachter] Prof. Dr. med. Keitel-Anselmino, Verena [Gutachter] | |||||||
Stichwörter: | Epidemiologie, Infektion, Sepsis, Septischer Schock, Zentrale Notaufnahme | |||||||
Dewey Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften » 610 Medizin und Gesundheit | |||||||
Beschreibungen: | Zusammenfassung
Bereits seit Jahrtausenden beschäftigt sich die Menschheit mit der Prävention und Behandlung von Infektionen: Sei es die Prävention durch Hygienemaßnahmen, durch Eindämmung impfpräventabler Infektionen (z.B. Masern oder Tetanus), durch Isolationsmaßnahmen bei Infektionen (z.B. Norovirus) oder auch die Behandlung bakterieller Infektionen mit Hilfe von Antiinfektiva zur Reduktion von Folgeerkrankungen und Mortalität. Infektionen können im Extremfall lebensbedrohliche Krankheitsbilder in Form einer Sepsis oder eines septischen Schockes annehmen, wobei Kleinkinder und alte Menschen als die vulnerabelsten Gruppen gelten. Epidemiologische Daten zu diesen Erkrankungsbildern stammen in aller Regel aus intensivmedizinischen Patientenkollektiven und zeigen deutliche Unterschiede hinsichtlich regionaler, demographischer sowie versorgungsspezifischer Variablen, sodass die Übertragung dieser Daten auf die Realität in Zentralen Notaufnahmen in Deutschland nicht vollständig gegeben ist. Die retrospektive, monozentrische EpiSEP- (Epidemiologie, Management und Behandlungsergebnisse von Infektionen, Sepsis und Septischem Schock in der Zentralen Notaufnahme) Studie ging nun erstmalig der Epidemiologie von Infektionen, Sepsis und septischen Schock in einer deutschen Zentralen Notaufnahme (ZNA) an einem Universitätsklinikum nach. In der Kohortenstudie wurden routinemäßig erfasste Daten aus dem Patienten-Daten-Management- System sowie dem Krankenhausinformationssystem ausgewertet. Eingeschlossen wurden alle erwachsenen Patienten, die sich in Zusammenhang mit einer Infektion im Studienzeitraum vom 01.01. bis 28.02.2019 in der ZNA des Universitätsklinikum Düsseldorf behandeln ließen. Ausschlusskriterien waren Patienten im Alter unter 18 Jahren sowie unvollständige Datensätze. Ein positives Ethikvotum der Medizinischen Fakultät der Heinrich-Heine-Universität lag vor (Studiennummer: 2020-973). Im benannten Studienzeitraum konnte bei 1.278 Patienten (19 %) von insgesamt 6.607 Notaufnahmekontakten eine Infektion nachgewiesen werden. Die Studienkohorte war zum Behandlungszeitpunkt im Mittel 56±23 Jahre alt, in 50 % männlichen Geschlechts und wurde zur weiteren Evaluation entsprechend der SEPSIS-3-Definition in drei Gruppen eingeteilt: Infektion (Gruppe I: 86 %), Sepsis (Gruppe II: 10 %), Septischer Schock (Gruppe III: 4 %). Gruppenübergreifend dominierten der Respirationstrakt (35 %) sowie der Urogenitaltrakt (18 %) als Infektfokusse. Bei 0,2 % der Patienten konnte kein Infektfokus im Rahmen der Behandlung in der Notaufnahme gefunden werden. Insgesamt zeigte sich eine hohe Leitlinienadhärenz zur S3-Leitlinie Sepsis mit zunehmender Krankheitsschwere. Die 30-Tages-Mortalität nahm über die drei Gruppen deutlich zu (1,6 %, 12 % und 38 %). Die retrospektive EpiSEP-Studie zeigt unter Berücksichtigung der geltenden Sepsisdefinitionen erstmals tatsächlichen Inzidenzraten von Infektionen, Sepsis und septischem Schock, deren Ursprung und wichtige Versorgungsdaten aus einer deutschen universitären ZNA.Abstract For thousands of years, humans have been engaged with the prevention and treatment of infections: Whether it is prevention through hygiene measures, through vaccine-preventable infections (e.g. measles or tetanus), through isolation procedures in the presence of infections (e.g. norovirus) or even the treatment of bacterial infections using anti-infectives to reduce secondary diseases and mortality. In extreme circumstances, infections can take on life-threatening clinical manifestations in the form of sepsis or septic shock, with young children and the elderly being considered the most vulnerable groups. Epidemiological data on these disease entities are usually based on intensive care patient populations and show significant differences with regard to regional, demographic and care-specific variables, so that the transfer of these data to the reality in central emergency departments in Germany is not completely given. The retrospective, single-center EpiSEP (Epidemiology, Management and Outcome of Infections, Sepsis and Septic Shock in the Central Emergency Department) study was the first to investigate the epidemiology of infections, sepsis and septic shock in a German emergency department at a university hospital. The cohort study evaluated routinely collected data from the patient data management system and the hospital information system. All adult patients who received treatment related to an infection in the emergency department of the University Hospital Düsseldorf during the study period from 01/01 to 28/02/2019 were included. Exclusion criteria were patients under 18 years of age and incomplete data sets. The study protocol was approved by the Medical Faculty of Heinrich Heine University (study number: 2020-973). During the study period, infection was detected in 1,278 patients (19 %) of a total of 6,607 emergency department visits. The study cohort had a mean age of 56±23 years, was male in 50 %, and was divided into three groups for further evaluation according to the SEPSIS-3 definition: Infection (group I: 86 %), Sepsis (group II: 10 %), Septic Shock (group III: 4 %). Across these groups, the respiratory tract (35 %) and genitourinary tract (18 %) were the predominant foci of infection. In 0.2 % of patients, no infectious focus could be identified during the treatment in the emergency department. Overall, there was a high guideline adherence to the S3 guideline sepsis with increasing disease severity. The 30-day mortality increased significantly across the three groups (1.6 %, 12 %, and 38 %, respectively). The retrospective EpiSEP study shows for the first time actual incidence rates of infections, sepsis and septic shock, their origin and important care data from a German university emergency department, taking into account the current sepsis definitions. | |||||||
Quelle: | 1. Deutsche Gesellschaft für Infektiologie e.V. (DGI). S3- Leitlinie. Strategien
zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. 2018; AWMF-Registernummer 092/001 – update 2018: URL: https://register.awmf.org/assets/guidelines/092-001l_S3_Strategien-zur- Sicherung-rationaler-Antibiotika-Anwendung-im-Krankenhaus_2020-02.pdf. (Stand 08.07.2023) 2. World Health Organization. Report on the Burden of Endemic Health Care- Associated Infection Worldwide. 2011; URL: https://apps.who.int/iris/bitstream/handle/10665/80135/9789241501507_en g.pdf. (Stand 22.01.2023) 3. SepNet Critical Care Trials, G., Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med, 2016. 42(12): p. 1980-1989. 4. Engel, C., et al., Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med, 2007. 33(4): p. 606-18. 5. Bauer, M., et al., Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care, 2020. 24(1): p. 239. 6. Gaieski, D.F., et al., Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med, 2013. 41(5): p. 1167-74. 7. Wang, H.E., et al., Long-term mortality after community-acquired sepsis: a longitudinal population-based cohort study. BMJ Open, 2014. 4(1): p. e004283. 8. Vincent, J.L., et al., The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA, 1995. 274(8): p. 639-44. 9. Vincent, J.L., et al., Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA, 2020. 323(15): p. 1478-1487. 10. Beale, R., et al., Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection, 2009. 37(3): p. 222-32. 11. Rudd, K.E., et al., Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet, 2020. 395(10219): p. 200-211. 46 12. Dombrovskiy, V.Y., et al., Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med, 2007. 35(5): p. 1244-50. 13. Sepsis Stiftung. Fakt oder Mythos? Der rote Strich als Sepsis-Symptom. 2019; URL: https://sepsis-stiftung.de/blog/fakt-oder-mythos-der-rote-strichals- sepsis-symptom/. (Stand 02.01.2024) 14. Moro, M.L., M. Mongardi, and M. Marchi, Healthcare-related infections outside the hospital: a new frontier for infection control. New Microbiol, 2007. 30(3): p. 350-4. 15. Eriksen, H.M., et al., Healthcare-associated infection among residents of long-term care facilities: a cohort and nested case-control study. J Hosp Infect, 2007. 65(4): p. 334-40. 16. Global Sepsis Alliance. World Sepsis Day Infographics - Prevention Save Lives. 2017; URL: https://www.global-sepsis-alliance.org/sepsis. (Stand 02.06.2023) 17. Robert Koch-Institut. Infektionsschutz und Infektionsepidemiologie Fachwörter – Definitionen – Interpretationen. 2015; URL: https://www.rki.de/DE/Content/Service/Publikationen/Fachwoerterbuch_Infe ktionsschutz.pdf?__blob=publicationFile. (Stand 14.12.2022) 18. Singer, M., et al., The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016. 315(8): p. 801-10. 19. Angus, D.C. and T. van der Poll, Severe sepsis and septic shock. N Engl J Med, 2013. 369(21): p. 2063. 20. Delano, M.J. and P.A. Ward, The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev, 2016. 274(1): p. 330-353. 21. Gotts, J.E. and M.A. Matthay, Sepsis: pathophysiology and clinical management. BMJ, 2016. 353: p. i1585. 22. Vincent, J.L., et al., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 1996. 22(7): p. 707-10. 23. Brunkhorst, F.M., et al., [S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations]. Med Klin Intensivmed Notfmed, 2020. 115(3): p. 178-188. 24. Evans, L., et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med, 2021. 49(11): p. e1063-e1143. 25. Levy, M.M., L.E. Evans, and A. Rhodes, The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med, 2018. 44(6): p. 925-928. 26. Long, B. and A. Koyfman, Clinical Mimics: An Emergency Medicine- Focused Review of Sepsis Mimics. J Emerg Med, 2017. 52(1): p. 34-42. 27. Seymour, C.W., et al., Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016. 315(8): p. 762-74. 28. Bayer, O., et al., An Early Warning Scoring System to Identify Septic Patients in the Prehospital Setting: The PRESEP Score. Acad Emerg Med, 2015. 22(7): p. 868-71. 29. Subbe, C.P., et al., Validation of a modified Early Warning Score in medical admissions. QJM, 2001. 94(10): p. 521-6. 30. Shapiro, N.I., et al., Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med, 2003. 31(3): p. 670-5. 31. Brunkhorst, F.M., et al., [S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations]. Med Klin Intensivmed Notfmed, 2020. 115(3): p. 178-188. 32. Deutsche Sepsis Gesellschaft e. V. S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge. 2018; URL: https://register.awmf.org/assets/guidelines/079-001l_S3_Sepsis- Praevention-Diagnose-Therapie-Nachsorge_2020-03_01.pdf. (Stand 04.01.2023) 33. Sunderkotter, C., et al., S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus "Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018". J Dtsch Dermatol Ges, 2019. 17(3): p. 345-371. 34. Hanses, F., [Anti-infective treatment : Treatment strategies for sepsis and septic shock]. Internist (Berl), 2020. 61(10): p. 1002-1009. 35. Wolfertz, N., et al., Epidemiology, management, and outcome of infection, sepsis, and septic shock in a German emergency department (EpiSEP study). Front Med (Lausanne), 2022. 9: p. 997992. 36. Fischer, M., et al., Eckpunktepapier 2016 zur notfallmedizinischen Versorgung der Bevölkerung in der Prähospitalphase und in der Klinik. Notfall + Rettungsmedizin, 2016. 19(5): p. 387-395. 37. Obermaier, M., et al., [Sepsis in out-of-hospital emergency medicine]. Notf Rett Med, 2022. 25(8): p. 541-551. 38. Gemeinsamer Bundesausschuss. Regelungen des Gemeinsamen Bundesausschusses zu einem gestuften System von Notfallstrukturen in 48 Krankenhäusern gemäß § 136c Absatz 4 des Fünften Buches Sozialgesetzbuch (SGB V). 2018 20. November 2020; URL: https://www.gba. de/downloads/62-492-2340/Not-Kra-R_2020-11-20_iK-2020-11-01.pdf. (Stand 03.10.2023) 39. Investigators, A., et al., Goal-directed resuscitation for patients with early septic shock. N Engl J Med, 2014. 371(16): p. 1496-506. 40. Mouncey, P.R., et al., Trial of early, goal-directed resuscitation for septic shock. N Engl J Med, 2015. 372(14): p. 1301-11. 41. Pro, C.I., et al., A randomized trial of protocol-based care for early septic shock. N Engl J Med, 2014. 370(18): p. 1683-93. 42. Levy, M.M., et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med, 2003. 29(4): p. 530-8. 43. Yu, C.W., et al., Epidemiology of Emergency Department Sepsis: A National Cohort Study Between 2001 and 2012. Shock, 2019. 51(5): p. 619- 624. 44. Klimpel, J., et al., The impact of the Sepsis-3 definition on ICU admission of patients with infection. Scand J Trauma Resusc Emerg Med, 2019. 27(1): p. 98. 45. Bloos, F., et al., Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care, 2014. 18(2): p. R42. 46. Abe, T., et al., Epidemiology of sepsis and septic shock in intensive care units between sepsis-2 and sepsis-3 populations: sepsis prognostication in intensive care unit and emergency room (SPICE-ICU). J Intensive Care, 2020. 8: p. 44. 47. Christ, M., et al., Modern triage in the emergency department. Dtsch Arztebl Int, 2010. 107(50): p. 892-8. 48. Michael, M., Al Agha, S., Böhm, L. et al., Alters- und geschlechtsbezogene Verteilung von Zuführung, Ersteinschätzung, Entlassart und Verweildauer in der zentralen Notaufnahme. Notfall Rettungsmed, 2023. 26: p. 39–48 49. Bone, R.C., et al., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992. 101(6): p. 1644-55. 50. Schmoch, T., Bernhard, M., Siegler, B.H. et al., Hämodynamische Stabilisierung des septischen Patienten in der Notaufnahme. Notfall Rettungsmed, 2018. 22: p. 205-218. 51. Reuss, C.J., et al., [Intensive care studies from 2016/2017]. Anaesthesist, 2017. 66(9): p. 690-713. 52. Schmoch, T., et al., [New Sepsis-3 definition : Do we have to treat sepsis before we can diagnose it from now on?]. Anaesthesist, 2017. 66(8): p. 614-621. 53. Donnelly, J.P., et al., Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective populationbased cohort study. Lancet Infect Dis, 2017. 17(6): p. 661-670. 54. Churpek, M.M., et al., Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit. Am J Respir Crit Care Med, 2017. 195(7): p. 906-911. 55. Kaukonen, K.M., et al., Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med, 2015. 372(17): p. 1629-38. 56. Richter, D.C., et al., [Bacterial sepsis : Diagnostics and calculated antibiotic therapy]. Anaesthesist, 2017. 66(10): p. 737-761. 57. Vincent, J.L., et al., International study of the prevalence and outcomes of infection in intensive care units. JAMA, 2009. 302(21): p. 2323-9. 58. Yealy, D.M., et al., Early Care of Adults With Suspected Sepsis in the Emergency Department and Out-of-Hospital Environment: A Consensus- Based Task Force Report. Ann Emerg Med, 2021. 78(1): p. 1-19. 59. Dodt, C., Sepsis in der Notaufnahme. Notaufnahme up2date, 2019. 1: p. 83-95. 60. Seymour, C.W., et al., Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med, 2017. 376(23): p. 2235-2244. 61. Casserly, B., et al., Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med, 2015. 43(3): p. 567-73. 62. Jouffroy, R., et al., Prehospital lactate clearance is associated with reduced mortality in patients with septic shock. Am J Emerg Med, 2021. 46: p. 367- 373. 63. Trzeciak, S., et al., Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med, 2007. 33(6): p. 970-7. 64. Orth, H.M., et al., [Optimization of microbial diagnostics by introduction of a blood culture standard operating procedure in the emergency department]. Med Klin Intensivmed Notfmed, 2021. 116(8): p. 687-693. 65. Briegel, J. and P. Möhnle, [Surviving Sepsis Campaign update 2018: the 1 h bundle : Background to the new recommendations]. Anaesthesist, 2019. 68(4): p. 204-207. 50 66. Marchick, M.R., J.A. Kline, and A.E. Jones, The significance of nonsustained hypotension in emergency department patients with sepsis. Intensive Care Med, 2009. 35(7): p. 1261-4. 67. Elbouhy, M.A., et al., Early Use of Norepinephrine Improves Survival in Septic Shock: Earlier than Early. Arch Med Res, 2019. 50(6): p. 325-332. 68. Rhodes, A., et al., The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med, 2015. 41(9): p. 1620-8. 69. Deutsche Gesellschaft für Unfallchirurgie e.V.. S3-Leitlinie Polytrauma / Schwerverletzten-Behandlung (AWMF Register-Nr.: 187-023). AWMF online 2022,Version 4.0 (31.12.2022); URL: https://register.awmf.org/assets/guidelines/187-023l_S3_Polytrauma- Schwerverletzten-Behandlung_2023-06.pdf. (Stand 10.06.2023) 70. Shapiro, N.I., M. Howell, and D. Talmor, A blueprint for a sepsis protocol. Acad Emerg Med, 2005. 12(4): p. 352-9. 71. Bernhard, M., et al., Resuscitation room management of critically ill nontraumatic patients in a German emergency department (OBSERvEstudy). Eur J Emerg Med, 2018. 25(4): p. e9-e17. 72. Dziegielewski, J., et al., Resuscitation room management of patients with non-traumatic critical illness in the emergency department (OBSERvEDUS- study). BMC Emerg Med, 2023. 23(1): p. 43. 73. Michael, M., et al., [Nontraumatic resuscitation room management of critically ill patients]. Med Klin Intensivmed Notfmed, 2021. 116(5): p. 405- 414. 74. Henriksen, D.P., et al., Incidence rate of community-acquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med, 2015. 43(1): p. 13-21. | |||||||
Lizenz: | ![]() Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
Bezug: | Studienzeitraum 01.01.2019-28.02.2019 | |||||||
Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
Dokument erstellt am: | 18.11.2024 | |||||||
Dateien geändert am: | 18.11.2024 | |||||||
Promotionsantrag am: | 16.04.2024 | |||||||
Datum der Promotion: | 29.10.2024 |